Evaluation of the two therapy-supporting smartphone apps for children (AUTHARK) and adolescents (JAY) for various internal and external mental disorders

Evaluation of the two therapy-supporting smartphone apps for children (AUTHARK) and adolescents (JAY) for various internal and external mental disorders - AUTHO - App assisted therapy optimization

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025717

Enrollment

Registered

2022-02-16

Start date

2022-02-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F90.0 F90.1 F90.9 F98.80 F91.0 F91.1 F91.2 F91.3 F91.9 F92.0 F32.0 F32.1 F32.2 F32.3 F32.8 F32.9 F40.0 F40.1 F40.8 F40.9 F41.0 F41.1 F41.2 F41.3 F41.8 F41.9 F34.1

Interventions

Group 1: All patients undergo a baseline phase after study inclusion (T1). The duration of this phase varies (three, six or nine weeks). Assignment to one of the three experimental experimental condi

Eligibility

Sex/Gender

All

Age

8 Years to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion is a clinical diagnosis of one of the following disorders according to ICD-10: Hyperkinetic disorders (F90.0, F90.1, F90.9, F98.80), Conduct disorders (F91.0, F91. 1, F91.2, F91.3, F91.9, F92.0), Depressive episodes (F32.0, F32.1, F32.2, F32.3, F32.8, F32.9), and Anxiety disorders (F40.0, F40.1, F40.8, F40.9, F41.0, F41.1, F41.2, F41.3, F41.8, F41.9, F34.1). Sufficient knowledge of German is another inclusion criterion.

Exclusion criteria

Exclusion criteria: Exclusion criteria are the diagnosis of a profound developmental disorder (ICD-10: F84.) or another mental disorder that is the primary focus of the treatment. Further exclusion criteria are an IQ below 80 as well as crisis-like culmination that indicate inpatient treatment. In addition, no other psychotherapy may be used in parallel and the indication for a new start of pharmacotherapy or a dosage change of an existing pharmacotherapy at the time of the intervention should be excluded.

Design outcomes

Primary

Measure	Time frame
The primary target variable is the change in individual behavior problems assessed via a behavior problem list (parent judgment, self-judgment).	—

Secondary

Measure	Time frame
As a secondary outcome measure, adherence to therapy tasks is recorded via the adherence questionnaire for therapy tasks and overall therapy adherence is recorded via the adherence questionnaire for the therapy (clinical judgment). Further secondary outcome measures will be the change in main symptomatology, the change in psychosocial functional impairment due to the symptomatology, as well as comorbid disorders in the parent and self-judgment as well as in the clinical judgment.	—

Measure

Time frame

As a secondary outcome measure, adherence to therapy tasks is recorded via the adherence questionnaire for therapy tasks and overall therapy adherence is recorded via the adherence questionnaire for the therapy (clinical judgment). Further secondary outcome measures will be the change in main symptomatology, the change in psychosocial functional impairment due to the symptomatology, as well as comorbid disorders in the parent and self-judgment as well as in the clinical judgment.

—

Countries

Germany

Contacts

Public ContactAnja Görtz-Dorten

Ausbildungsinstitut für Kinder- und Jugendlichenpsychotherapie der Uniklinik KölnEvaluation/ Forschungsbereich PsychotherapieKölner Institut der Christoph-Dornier-Stiftung fürKlinische Kinderpsychologie

anja.goertz-dorten@uk-koeln.de0221 478-76836

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026